The pharmaceutical industry is constantly striving for innovation, developing new drugs and improving existing treatments to address global health challenges. Central to this progress is the availability of high-quality pharmaceutical intermediates, compounds that form the backbone of API synthesis. 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene, identified by CAS number 1103738-29-9, stands out as a critical player in this domain. As a premier pharmaceutical intermediate supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. recognizes the immense value of this compound, particularly its indispensable role in the synthesis of Ipragliflozin, a significant drug for managing type 2 diabetes.

The value of 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene is deeply rooted in its chemical structure and purity. With a molecular formula of C15H14ClIO and a molecular weight of 372.63, this compound possesses a unique arrangement of halogen atoms and aromatic rings that makes it an ideal precursor for complex organic synthesis. The high purity, typically exceeding 99.0%, is paramount for pharmaceutical applications, ensuring that subsequent reactions proceed smoothly and that the final API meets stringent regulatory standards. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing this level of quality, positioning itself as a reliable 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene manufacturer in China. Businesses seeking to buy 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene can trust our manufacturing processes to deliver excellence.

The primary application of this intermediate is in the synthesis of Ipragliflozin, a selective SGLT2 inhibitor. Ipragliflozin aids in blood sugar regulation for individuals with type 2 diabetes by promoting glucose excretion. The precise molecular architecture of Ipragliflozin requires intermediates that contribute specific functional groups and structural elements. 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene serves this purpose effectively, enabling chemists to build the complex Ipragliflozin molecule through carefully designed reaction pathways. The efficiency and success of this synthesis directly depend on the quality of the intermediate, highlighting the importance of sourcing from reputable pharmaceutical intermediates suppliers in China.

Beyond its direct application in Ipragliflozin synthesis, 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene represents the broader advancements in organic synthesis and fine chemical production. The ability to reliably produce such complex molecules in high purity underscores the sophistication of modern chemical manufacturing. For companies aiming to optimize their production costs without compromising quality, partnering with Chinese manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. offers a strategic advantage. We not only provide the necessary chemical intermediates but also the technical support and assurance of supply that are crucial for uninterrupted production cycles. Our expertise ensures that your procurement of this vital intermediate is seamless.

In conclusion, 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene (CAS 1103738-29-9) is a testament to the power of specialized chemical intermediates in advancing pharmaceutical science. Its high purity and specific chemical properties make it an invaluable component in the development of treatments for conditions like type 2 diabetes. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to being a leading provider of these essential materials, supporting global pharmaceutical innovation from our base as a trusted pharmaceutical intermediates supplier in China.